Clinical Trials in El Segundo, California
5 recruiting
Showing 1–5 of 5 trials
Recruiting
Phase 1Phase 2
A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer
PDAC - Pancreatic Ductal AdenocarcinomaPancreatic Cancer Metastatic
Engeneic Pty Limited144 enrolled4 locationsNCT07049055
Recruiting
Phase 2
N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma
Glioblastoma
ImmunityBio, Inc.34 enrolled4 locationsNCT06061809
Recruiting
Phase 3
ResQ201A: Clinical Trial Of N-803 Plus TISLELIZUMAB And DOCETAXEL Versus DOCETAXEL Monotherapy In Participants With Advanced Or Metastatic Non-Small Cell Lung Cancer
NSCLC Stage IV
ImmunityBio, Inc.460 enrolled9 locationsNCT06745908
Recruiting
Phase 2
A Study to Examine Anktiva for the Treatment of COVID-19.
Long COVIDLong COVID SyndromeLong Covid 19
ImmunityBio, Inc.40 enrolled1 locationNCT07123727
Recruiting
Phase 2
A Phase 2, Open-label, Single-arm Study Of Autologous M-CENK Adoptive Cell Therapy And N-803 (IL-15 Superagonist) In Combination With Gemcitabine In Participants With Recurrent Platinum-Resistant High-Grade Ovarian Cancer
Platinum Resistant Ovarian Cancer
ImmunityBio, Inc.20 enrolled2 locationsNCT06710288